Literature DB >> 15948006

Stability of alpha-[11C]methyl-L-tryptophan brain trapping in healthy male volunteers.

Pedro Rosa-Neto1, Mirko Diksic, Marco Leyton, Shadreck Mzengeza, Chawki Benkelfat.   

Abstract

PURPOSE: The purpose of this study was to assess the reproducibility in healthy volunteers of alpha-[11C]methyl-L-tryptophan (alpha[11C]MT) brain trapping imaging with positron emission tomography (PET), using volumes of interest (VOIs) and voxel-based image analysis.
METHODS: Six right-handed healthy male volunteers (34.3+/-10.9 years) with a negative family history for psychiatric disorders were scanned twice in the resting condition, 22+/-17 days apart. An unbiased semiautomatic segmentation of the brain was used to define VOIs. The trapping constant K* (ml g(-1) min(-1)) for alpha[11C]MT was calculated for the whole brain and seven brain regions using the graphical method for irreversible tracers. In addition, parametric maps of K* were obtained from dynamic scans using the same method. Comparison of test and retest K* functional images was performed using SPM99. Student's paired t statistic was applied for comparisons of alpha[11C]MT brain trapping in a priori selected VOIs.
RESULTS: alpha[11C]MT brain trapping in VOIs showed a mean variability 2.6+/-1.8% (0.3-5%) for absolute and 1.5+/-2.1% (1.4-4.1%) for normalized K*. Intraclass correlations between test and retest conditions were 0.61+/-0.34 for absolute K* values and 0.73+/-0.20 for K* values normalized by global mean. SPM99 analysis using a height threshold of p=0.05 (two tailed) and an extent threshold of 100 voxels showed no significant differences between scans.
CONCLUSION: Rest measurements in healthy male volunteers of the trapping constant for alpha[11C]MT, using PET, appeared to be stable during an average interval of 3 weeks.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948006     DOI: 10.1007/s00259-005-1829-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  22 in total

1.  Functional cerebral activity of an analogue of serotonin formed in situ.

Authors:  K Missala; T L Sourkes
Journal:  Neurochem Int       Date:  1988       Impact factor: 3.921

2.  Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder.

Authors:  M Leyton; H Okazawa; M Diksic; J Paris; P Rosa; S Mzengeza; S N Young; P Blier; C Benkelfat
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

3.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data.

Authors:  J G Sled; A P Zijdenbos; A C Evans
Journal:  IEEE Trans Med Imaging       Date:  1998-02       Impact factor: 10.048

4.  Brain net unidirectional uptake of alpha-[14c]methyl-L-tryptophan (alpha-MTrp) and its correlation with regional serotonin synthesis, tryptophan incorporation into proteins, and permeability surface area products of tryptophan and alpha-MTrp.

Authors:  M Diksic; Y Tohyama; A Takada
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

5.  Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space.

Authors:  D L Collins; P Neelin; T M Peters; A C Evans
Journal:  J Comput Assist Tomogr       Date:  1994 Mar-Apr       Impact factor: 1.826

6.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

7.  Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.

Authors:  J P Seibyl; M Laruelle; C H van Dyck; E Wallace; R M Baldwin; S Zoghbi; Y Zea-Ponce; J L Neumeyer; D S Charney; P B Hoffer; R B Innis
Journal:  J Nucl Med       Date:  1996-02       Impact factor: 10.057

8.  Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.

Authors:  P Maquet; D Dive; E Salmon; R von Frenckel; G Franck
Journal:  Eur J Nucl Med       Date:  1990

9.  Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys.

Authors:  W P Melega; M J Raleigh; D B Stout; A A DeSalles; S R Cherry; M Blurton-Jones; G G Morton; S C Huang; M E Phelps
Journal:  Exp Neurol       Date:  1996-10       Impact factor: 5.330

10.  A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model.

Authors:  M Diksic; S Nagahiro; T L Sourkes; Y L Yamamoto
Journal:  J Cereb Blood Flow Metab       Date:  1990-01       Impact factor: 6.200

View more
  4 in total

1.  Brain serotonin synthesis in adult males characterized by physical aggression during childhood: a 21-year longitudinal study.

Authors:  Linda Booij; Richard E Tremblay; Marco Leyton; Jean R Séguin; Frank Vitaro; Paul Gravel; Elisabeth Perreau-Linck; Mélissa L Lévesque; France Durand; Mirko Diksic; Gustavo Turecki; Chawki Benkelfat
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

2.  In vivo measurements of brain trapping of C-labelled alpha-methyl-L-tryptophan during acute changes in mood states.

Authors:  Elisabeth Perreau-Linck; Mario Beauregard; Paul Gravel; Vincent Paquette; Jean-Paul Soucy; Mirko Diksic; Chawki Benkelfat
Journal:  J Psychiatry Neurosci       Date:  2007-11       Impact factor: 6.186

3.  Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect.

Authors:  Pedro Rosa-Neto; Chawki Benkelfat; Yojiro Sakai; Marco Leyton; Jose A Morais; Mirko Diksic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-21       Impact factor: 10.057

4.  Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.

Authors:  Jennifer I Lissemore; Debbie Sookman; Paul Gravel; Alexandre Berney; Amir Barsoum; Mirko Diksic; Thomas E Nordahl; Gilbert Pinard; Igor Sibon; Jean Cottraux; Marco Leyton; Chawki Benkelfat
Journal:  Transl Psychiatry       Date:  2018-04-18       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.